Triple threat: new antibody takes on tough tumors
Disease control
Recruiting now
This study tests a new drug called CS2009, which targets three different proteins on cancer cells to help the immune system fight tumors. It is for people with advanced solid tumors that have not responded to other treatments. The trial has two parts: first, finding the safest do…
Phase: PHASE1, PHASE2 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:32 UTC